Mode
Text Size
Log in / Sign up

Intraprocedural atrial tachycardia incidence and 12-month outcomes after RFCA for paroxysmal AFPatients with atrial tachycardia during ablation have similar long-term rhythm success to others

AI-generated summary of the cited source, checked by automated accuracy review. How we work

Key Takeaway
Consider that intraprocedural atrial tachycardia during RFCA for paroxysmal AF does not significantly alter 12-month sinus rhythm maintenance rates.

This was a single-center, prospective cohort study of 255 patients undergoing radiofrequency catheter ablation (RFCA) for paroxysmal atrial fibrillation (PAF). The study examined the incidence and impact of intraprocedural atrial tachycardia (IAT) during the ablation procedure.

The incidence of IAT was 13.33%. Right atrial enlargement was identified as an independent risk factor for atrial tachycardia (OR = 1.14, P = 0.015). The overall 12-month sinus rhythm maintenance rate was 78.0%. When comparing groups, the rate was 79.4% for patients with IAT versus 77.8% for non-IAT patients, a difference that was not statistically significant (P = 0.84).

The mechanisms of IAT were macro-reentrant circuits around the tricuspid and mitral annuli, with 45% peri-tricuspid, 45% peri-mitral, 2.5% roof-dependent, and 7.5% focal. No safety or tolerability data were reported.

Key limitations include the single-center design. The practice relevance suggests that IAT patients can achieve a 12-month prognosis similar to non-IAT patients with successful intra-procedural identification and targeted ablation. These findings are observational and should not be used to infer causality.

This study looked at 255 patients who underwent radiofrequency catheter ablation (RFCA) for paroxysmal atrial fibrillation. Researchers specifically examined those who developed intraprocedural atrial tachycardia (IAT) during the surgery compared to patients who did not have this complication. The main goal was to see if having IAT affected how well patients maintained a normal heart rhythm one year later.

The team found that 13.33% of patients experienced IAT during the procedure. Despite this complication, the overall rate of maintaining sinus rhythm at 12 months was 78.0%. When comparing the two groups directly, patients with IAT had a 12-month success rate of 79.4%, while those without IAT had a rate of 77.8%. This difference was not statistically significant, meaning the presence of IAT did not lead to worse long-term results.

Researchers also identified right atrial enlargement as an independent risk factor for developing IAT. They observed that most of these tachycardias involved macro-reentrant circuits around the tricuspid or mitral annuli. The study was conducted at a single center, which limits how broadly these results can be applied immediately. However, the findings suggest that identifying and treating IAT during the procedure allows patients to achieve a prognosis similar to those without the complication.

What this means for you:
Patients with atrial tachycardia during ablation can achieve similar long-term rhythm success to others if treated.

Study Details

Study typeCohort
EvidenceLevel 3
PublishedApr 2026
View Original Abstract ↓
BackgroundRadiofrequency catheter ablation (RFCA) is the mainstay treatment for paroxysmal atrial fibrillation (PAF). However, the incidence, risk factors, and impact of intra-procedural atrial tachycardia (IAT) during PAF ablation remain insufficiently characterized. The purpose of this study was to explore the incidence, risk factors, electrophysiological features, and clinical outcomes of IAT.MethodsIn this single-center, prospective study, 255 patients undergoing RFCA for PAF were analyzed. IAT was defined as stable tachycardia lasting more than 2 min, either induced or spontaneous. Logistic regression identified risk factors for AT, and Kaplan–Meier analysis was used to examine its impact on long-term success.ResultsIAT occurred in 13.33% of patients. Right atrial enlargement was identified as an independent risk factor [odds ratio (OR) = 1.14, P = 0.015], and AT involving the peri-tricuspid (45%), peri-mitral (45%), roof-dependent (2.5%) and focal (7.5%) types were found. The overall 12-month sinus rhythm maintenance rate was 78.0%, with no significant difference between the AT and non-AT groups (79.4% vs. 77.8%, P = 0.84).ConclusionsIAT was observed in 13.3% of patients undergoing PAF ablation, with macro-reentrant circuits around the tricuspid and mitral annuli being the primary mechanisms. Right atrial diameter served as a key predictor. Our data demonstrate that with successful intra-procedural identification and targeted ablation, IAT patients can achieve a 12-month prognosis similar to non-IAT patients.
Free Newsletter

Clinical research that matters. Delivered to your inbox.

Join thousands of clinicians and researchers. No spam, unsubscribe anytime.